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Abstract
Background: Selenium is an essential micronutrient known for its antioxidant function. However, the association of 
serum selenium with lipid profiles and fasting glucose are inconsistent in populations with average intake of selenium. 
Furthermore, there were few studies conducted specifically for the elderly. This study examined the relationship of 
serum selenium concentration with serum lipids and fasting glucose in the Taiwanese elderly population.
Methods: This was a cross-sectional study of 200 males and females aged 65-85 years (mean 71.5 ± 4.6 years) from 
Taipei, Taiwan. Serum selenium was measured by inductively coupled plasma-mass spectrometer. The association 
between serum selenium and metabolic factors was examined using a multivariate linear regression analysis after 
controlling several confounders.
Results: The mean serum selenium concentration was 1.14 μmol/L, without significant difference between sexes. Total 
cholesterol, triglycerides, and LDL cholesterol increased significantly with serum selenium concentration (P < 0.001, P < 
0.05 and P < 0.001, respectively) after adjusting for age, gender, anthropometric indices, lifestyle factors, and cardio-
vascular risk factors in several linear regression models. Furthermore, there was a significantly positive association 
between serum selenium and serum fasting glucose concentrations (P < 0.05).
Conclusions: Total cholesterol, triglycerides, and LDL cholesterol, and fasting serum glucose concentrations increased 
significantly with serum selenium concentration in the Taiwanese elderly. The underlying mechanism warrants further 
research.
Background
Selenium, an essential trace element, is vital for human
normal development, growth, male fertility, and thyroid
hormone metabolism. Selenium deficiency is associated
with Keshan disease, an endemic cardiomyopathy, and
Kashin-Beck disease, a deforming arthritis. Less-overt
deficiency may cause disease susceptibility and poor
health maintenance [1]. Selenoproteins reportedly pos-
sess antioxidant properties and its deficiency plays an
important role in the pathogenesis of cardiovascular dis-
ease (CVD). However, whether or not selenium concen-
tration contributes to CVD remains uncertain. For
example, epidemiologic studies show that low serum sele-
nium is associated with increased cardiovascular mortal-
ity [2-4]. On the other hand, there is no significant
correlation between selenium and risk of myocardial
infarction [5] and peripheral artery disease [6] in sele-
nium-replete population such as United States.
Some studies propose that selenium may exert its influ-
ence on CVD through its effect on known CVD risk fac-
tors, including dyslipidemia and hyperglycemia.
Observational studies show positive associations of
serum selenium with total cholesterol, low-density lipo-
protein (LDL) cholesterol, and triglycerides concentra-
tions in high selenium-replete populations [7-9].
However, in populations with low serum selenium con-
centrations, the associations are inconsistent [10-19].
Similarly inconsistent is the association between serum
selenium and fasting glucose concentrations [7,20-22].
Potential adverse effects of high selenium exposure on
diabetes risk have been noted [23-26]. Nonetheless, most
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studies involve relatively young populations. Few studies
have focused on the elderly.
Since CVD is a leading cause of death in the elderly, the
relationship between serum selenium concentrations and
metabolic factors deserves further studies. This study
aimed to evaluate the relationship between serum sele-
nium and metabolic factors, including serum lipid and
glucose concentrations, in a cohort of Taiwanese elderly.
Methods
Subjects
A total of two hundred ambulatory elderly volunteers liv-
ing in the Taipei area were invited to our study in 2007.
Information about age, sex, cigarette smoking, alcohol
consumption, physical activity, CVD history, current use
of cholesterol-lowering medications, current use of vita-
min-mineral supplements, and current use of hormone
replacement therapy were obtained by individual inter-
view through questionnaires. Current smokers were
defined as those with smoking recently for more than six
months. Former smokers were defined as quitting smok-
ing for at least one year. Former smokers and never smok-
ers were grouped together as non-current smokers for
further analysis. Current drinkers of alcohol were defined
as those with drinking at least one ounce of alcohol per
week for six months. Former drinkers were defined as
quitting drinking for at least one year. Former drinkers
and never drinker were grouped together as non-current
drinker for further analysis. Current use of cholesterol-
lowering medications was defined as participants using
medication regularly. Current use of vitamin-mineral
supplements was defined as participants taking supple-
ments daily or at least weekly. Vitamin-mineral supple-
ments included multivitamin, vitamin B complex,
calcium supplement, glucosamine sulfate, collagen sup-
plement and cod liver oil, etc. Current use of hormone
replacement therapy was defined as taking hormone reg-
ularly. Anthropometric measurements, including height
and weight, were performed using a standard stadiome-
ter. Body mass index (BMI) was calculated as weight (kg)
divided by height squared (m2). Diabetes mellitus (DM)
and hypertension were defined based on self-reported
history or current medication use for DM and hyperten-
sion.
Blood analyses
Venous blood sample was taken after an eight-hour fast-
ing at least. Serum glucose, total cholesterol, high-density
lipoprotein (HDL) cholesterol, LDL cholesterol, and trig-
lycerides were assessed by automatic spectrophotometric
assay (HITACHI 7170, Japan). Fasting glucose was deter-
mined using glucose oxidase method. Using free glycerol
banking method to determine serum triglycerides. HDL
and LDL were determined by chemical modified enzyme
and sodium N-(2-Hydroxy-3-sulfopropyl)-3.5-dime-
thoxyaniline (HSDA). Serum selenium was measured
using inductively coupled plasma mass spectroscopy
(ICP-MS). Serum samples were diluted 1:24 with diluents
of 0.1% nitric acid and 0.1% Triton X-100. The calibration
standards were prepared in a blank matrix and run using
the standard addition calibration type. The serum sam-
ples were analyzed in the peak-jumping mode for 82Se,
with the detection limit set at 0.01 μmol/L. Accuracy of
the analysis was checked against Seronorm Trace Ele-
ment Human Serum (batch 704121; Nycomed AS, Oslo,
Norway) as reference material. The National Health Insti-
tute in Taiwan approved this study. All of the participants
provided informed consents.
Statistical analysis
Data were presented as means and standard deviations
(mean ± SD) and percentages. Participants were divided
into four groups according to their serum selenium con-
centrations. Anthropometric and biochemical variables
were compared across the four quartiles. Tests for trend
across serum selenium quartiles were calculated by enter-
ing the quartile as an ordinal number in a regression
model. Using one-way analysis of variance, the study had
a 83% power to detect the difference in means of total
cholesterol levels with 50 subjects in each group and with
an alpha of 0.05 characterized by a variance of 0.057,
assuming that the common standard deviation is 0.970.
The relationship between serum selenium concentra-
tions and lipids and fasting glucose were analyzed using
several multivariate linear regression models with lipids
and fasting glucose as dependent variables, and serum
selenium as independent variable. Other possible con-
founders were adjusted for models 1~3 as independent
variables. In model 1, age, sex and BMI were adjusted. In
model 2, current smoking, current drinking, vegetarian
diet, and physical activity were further adjusted. In model
3, hormone replacement therapy, cholesterol-lowering
medication, vitamin supplement, diabetes mellitus, and
hypertension were also further adjusted. For fasting glu-
cose, a "modified" model 3 was applied after excluding
diabetes mellitus from the independent variables in
model 3. Log transformation of the variables was per-
formed if they were not normally distributed as assessed
by the Kolmogorov-Smirnov test. The least square (LS)
means of lipids and glucose concentration were com-
puted by general linear models adjusted for the indepen-
dent variables among the four selenium quartile groups.
Statistical analyses were performed using the SPSS statis-
tical software (13th version, SPSS Inc., Chicago, IL, USA).
Results
The basic characteristics of the subjects were shown in
Table 1. Their average age was 71.5 ± 4.6 years and mean
serum selenium concentration was 1.14 ± 0.23 μmol/L.
Serum total, LDL and HDL cholesterol were significantlyYang et al. Nutrition & Metabolism 2010, 7:38
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higher in women (P < 0.001, P = 0.016 and P < 0.001,
respectively) than in men but there was no significant dif-
ference in their selenium levels. However, fasting glucose
was significantly higher in men than in women (P  =
0.036). In Table 1, the means of total, LDL cholesterol,
triglycerides, and fasting glucose concentrations were sig-
nificantly different among the four selenium quartiles
(test for trend, P = 0.0004, P = 0.02, P = 0.0008 and P =
0.04, respectively). In sex specific analyses, the means of
triglycerides and fasting glucose concentrations increased
significantly across the four selenium quartiles in men (P
= 0.01 and P = 0.001, respectively) while the means of
total, HDL and LDL cholesterol concentrations increased
significantly across the four selenium quartiles (P  <
0.0001, P = 0.028 and P < 0.0001, respectively) in women.
The characteristics among the four selenium quartiles
separately for men and women were shown in additional
file 1, Table S1 and Table S2, respectively.
Serum selenium concentration was positively associ-
ated with serum total, LDL cholesterol, and triglycerides
using multivariate linear regression analyses adjusting for
various confounders in Models 1-3 in Table 2. Serum
fasting glucose was also positively associated with serum
selenium in Model 1, Model 2 and "modified" Model 3 (P
= 0.026, P = 0.034 and P = 0.03, respectively). The result
of sex-specific analyses was provided in additional file 1,
Table S3 and Table S4.
The LS means of total, LDL, HDL cholesterol, and trig-
lycerides in the four selenium quartiles were shown in
Figure 1. The LS means of total (Figure 1A), LDL choles-
terol (Figure 1B), and triglycerides (Figure 1D) increased
significantly with increments of serum selenium
quartiles. However, no significant difference was found in
the LS means of HDL cholesterol (Figure 1C) with incre-
ments of serum selenium.
Discussion
In this study, serum selenium concentrations were posi-
tively associated with serum concentrations of total cho-
lesterol, LDL cholesterol, triglycerides, and glucose in the
Table 1: General characteristics among quartiles of serum selenium concentrations
Q1 (n = 50) Q2 (n = 51) Q3 (n = 49) Q4 (n = 50)
<0.98 μmol/L 0.98-1.136 μmol/L 1.14-1.30 μmol/L >1.30 μmol/L P for trenda
Age (y) 71.8 ± 5.2 70.1 ± 3.9 71.6 ± 4.8 72.5 ± 4.4 0.235
Sex, male (%) 26 27.5 34.7 38 0.141
Body weight (kg) 57.7 ± 10.7 58.3 ± 9.8 57.7 ± 8.6 56.2 ± 10.1 0.521
WC (cm) 82.4 ± 10.6 82.3 ± 8.9 82.2 ± 8.3 80.1 ± 10.3 0.253
BMI (kg/m2) 23.9 ± 3.7 23.7 ± 3.1 23.5 ± 2.6 22.6 ± 3.2 0.049
TCHO (mmol/L) 5.06 ± 0.83 5.27 ± 0.88 5.38 ± 1.03 5.72 ± 1.01 0.0004
LnTG (mmol/L) 0.1 ± 0.44 0.2 ± 0.49 0.29 ± 0.46 0.31 ± 0.51 0.002
HDL-C (mmol/L) 1.44 ± 0.27 1.49 ± 0.37 1.5 ± 0.46 1.52 ± 0.35 0.271
LDL-C (mmol/L) 3.01 ± 0.69 3.1 ± 0.64 3.2 ± 0.7 3.47 ± 0.71 0.0008
Sugar-AC (mmol/L) 5.34 ± 0.73 5.68 ± 1.28 5.63 ± 0.76 5.84 ± 1.45 0.04
Se (μmol/L) 0.85 ± 0.09 1.07 ± 0.04 1.22 ± 0.05 1.44 ± 0.1 <0.0001
C u r r e n t  s m o k i n g  ( % ) 4 9 . 86 . 16 . 10 . 9
Current drinking (%) 14 17.6 16.3 10.0 0.547
H T N  ( % ) 4 84 5 . 14 9 4 4 0 . 7 9 6
DM (%) 8 11.8 20.4 8 0.7
Lipid Tx (%) 22 17.6 20.4 24 0.732
V e g e t a r i a n  ( % ) 4206 0 . 7 0 3
Exercise (min/week) 340.6 ± 199.3 334.8 ± 224.5 322.8 ± 240.7 333.0 ± 239.2 0.808
Vitamin-mineral 
supplement users (%)
78 84.3 85.7 90 0.102
Abbreviations: WC, waist circumference; TCHO, total cholesterol; LnTG, log transformation of triglycerides; HDL-C, high-density lipoprotein 
cholesterol; LDL-C, low-density lipoprotein cholesterol; Se, serum selenium; Sugar-AC, fasting serum glucose; HTN, hypertension; DM, diabetes 
mellitus; Lipid Tx, hyperlipidemia treatment; HRT, hormone replacement treatment.
aP value for trend in percentages or means across quartiles of serum seleniumYang et al. Nutrition & Metabolism 2010, 7:38
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elderly, after adjustment for age, gender, anthropometric
indices, lifestyles, and traditional CVD risk factors. This
suggests that high serum selenium concentrations may be
associated with risk factors of CVD in the elderly.
Positive relationships between serum selenium and
total cholesterol concentrations are discussed in several
studies of various serum selenium concentrations
[2,4,7,10-15,19,27]. However, most participants have
been young and middle-aged adults. Similar to two stud-
ies involving the elderly [4,14,15], this study showed that
serum total cholesterol concentration was positively
associated with serum selenium concentration (Table 2;
Fig. 1A).
Many studies failed to show a significant association
between serum selenium and triglycerides concentrations
[10,12,27] and only two have shown a positive association
[7,8]. Our study demonstrated that serum selenium con-
centrations were positively associated with serum triglyc-
erides (Table 2; Fig. 1D).
The association between serum selenium and LDL cho-
lesterol levels was not consistent in previous studies. Five
studies showed a positive association [7-9,13,14] but oth-
ers revealed no significant relationship [11,16-18]. The
variable sample sizes, age groups, and lack of adjustments
for possible confounders may account for the inconsis-
tencies in those studies. Our present study supported that
serum LDL cholesterol concentrations were positively
associated with serum selenium levels (Table 2; Fig. 1B).
The association of serum selenium with HDL choles-
terol is not consistent in previous studies. Five studies
report a positive association [8,9,11,15,16], one has a neg-
ative association [7], and three do not show any signifi-
cant association [10,12,19]. In our present study, the HDL
cholesterol concentrations did not increase significantly
with increments of serum selenium (Table 2; Fig. 1C). In
addition, the mean HDL cholesterol concentration was
higher in our population as compared to those in previ-
ous studies.
Interestingly, the effects of selenium supplementation
on blood lipids are contradictory in animal and human
studies. In rats, selenium supplementation increases LDL
receptor activity [28,29] but decreases 3-hydroxy 3-meth-
ylglutaryl co-enzyme A (HMG-CoA) reductase expres-
sion [30], leading to decreased plasma LDL cholesterol
and total cholesterol levels. However, one animal study in
mice showed a significant increase in plasma cholesterol
with the loss of housekeeping selenoprotein expression
[31]. In human, selenium supplementation was found to
increase total cholesterol and triglyceride levels in French
adults [27]. Total cholesterol and LDL cholesterol levels
also increased after selenium supplementation in the Chi-
nese population [32]. Another study showed no further
decrease in triglyceride or LDL cholesterol concentration
but a blunted increment of HDL with selenium supple-
mentation in participants with coronary heart disease
receiving simvastatin-niacin treatment [33]. Therefore,
the role of selenium supplementation on lipid metabo-
lism in humans deserves further research. Recently, the
apoE δ4 gene was found to play a central role between
selenium levels and lipid metabolism in rural elderly Chi-
nese [34]. The underlying interactive mechanism
between susceptible gene, selenium, and lipids needs fur-
ther investigation.
High serum selenium concentrations also correlate
with high fasting glucose concentrations [7,20]. The prev-
alence of type 2 diabetes increases with increment of
serum selenium in American adults [23]. Further analysis
of the study shows that glycosylated hemoglobin levels
increase with increasing selenium concentrations [26].
Similarly, serum selenium level was positively associated
with glucose level in Table 2. Stranges et al note increased
risk of diabetes after receiving selenium supplements for
Table 2: Linear regression models showing standardized betas with serum selenium concentrations as independent 
variable











Model 1 0.276 <0.001 0.194 0.006 0.086 0.204 0.259 <0.001 0.157 0.026
Model 2 0.275 <0.001 0.189 0.007 0.086 0.185 0.257 <0.001 0.15 0.034
Model 3 0.294 <0.001 0.183 0.012 0.093 0.173 0.279 <0.001 0.156a 0.03a
Abbreviations: TCHO, total cholesterol; LnTG, log transformation of triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-
density lipoprotein cholesterol; Se, serum selenium; Sugar-AC, fasting serum glucose
Model 1: adjusted for age, sex, and BMI
Model 2: adjusted for age, sex, BMI, current smoking, current drinking and vegetarianx diet, and physical activity
Model 3: adjusted for age, sex, BMI, current smoking, current drinking and vegetarian diet, and physical activity, hormone replacement 
therapy, cholesterol-lowering medication, Vitamin supplement, diabetes mellitus, hypertension
a "Modified" Model 3: Diabetes mellitus was excluded in Model 3Yang et al. Nutrition & Metabolism 2010, 7:38
http://www.nutritionandmetabolism.com/content/7/1/38
Page 5 of 7
7.7 years [24]. Lipman et al also found a statistically non-
significant increase in diabetes after selenium supple-
mentation for 5.46 years [25]. Interestingly, over-produc-
tion of selenium-dependent glutathione peroxidase-1 can
i n d u c e  h y p e r i n s u l i n e m i a  i n  m i c e  [ 3 5 ] .  I n  c o n t r a s t ,
Hughes et al showed no significant difference in serum
selenium levels between diabetic and non-diabetic Singa-
poreans [36]. Recently, Akbaraly et al found that higher
serum selenium status at baseline had protective effect on
later occurrence of dysglycemia in a 9-year longitudinal
study [22]. Besides, supplementation of selenium can lead
to increased insulin sensitivity in rats [37]. Therefore, the
inconsistent results of various studies imply that further
research is warranted.
Although this study shows that elevated serum sele-
nium concentrations are associated with metabolic fac-
t o r s  i n  a n  e l d e r l y  p o p u l a t i o n ,  i t  h a s  s o m e  l i m i t a t i o n s .
First, the study has a cross-sectional design and causal
inference cannot be established. Second, the participants
are volunteers rather than randomly selected. External
validation is necessary in future studies. In addition, there
is no human selenium survey in Taiwan. Thus, a compar-
ison of serum selenium concentrations between the data
here and the Taiwanese data is not possible. Thirdly, there
is no available data on food intake and selenium supple-
mentation, which may indicate a possible residual con-
founding effect. Fourth, multivariate analyses adjusted for
lipid-lowering medications might bias the results [38].
Figure 1 Relationship between serum selenium and total (A), LDL (B), HDL cholesterol (C), and triglycerides (D) levels. The least square (LS) 
means of serum lipid in the quartiles of serum selenium (<0.98 μmol/L, 0.98-1.136 μmol/L, 1.14-1.3 μmol/L, >1.3 μmol/L in serum selenium) using gen-
eral linear model after adjustment for confounders in model 3. Covariates appearing in the models were estimated with the following values: age = 
71.4968, sex = 0.69, BMI = 23.423, current smoking = 0.065, current drinking = 0.145, vegetarian diet = 0.03, physical activity = 332.85, hormone re-
placement therapy = 0.18, cholesterol-lowering medication = 0.21, vitamin supplement = 0.77, diabetes mellitus = 0.12, hypertension = 0.465. The LS 
means of total cholesterol increased with the increments of serum selenium (P for trend < 0.001); the LS means of log transformation of triglycerides 
increased with increments of serum selenium (P for trend < 0.01); the LS means of LDL cholesterol increased with increments of serum selenium (P for 
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Finally, only the serum fasting glucose without insulin
levels was available in the study. Therefore, the relation-
ship between selenium with insulin resistance could not
be explored.
Conclusions
In conclusion, serum selenium concentration was associ-
ated with serum concentrations of total, LDL cholesterol,
triglycerides, and glucose in the elderly after adjustment
for potential confounders. The role of selenium on lipid
and glucose metabolism in humans deserves further
research in the future. Thus, recommendations on sele-
nium supplementation should be carefully evaluated.
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